HEADER BIOSYNTHETIC PROTEIN 13-JAN-23 8I1N TITLE CRYSTAL STRUCTURE OF APSK2 DOMAIN FROM HUMAN PAPSS2 IN COMPLEX WITH TITLE 2 ENDOGENOUS APS AND ADP COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE SYNTHASE COMPND 3 2; COMPND 4 CHAIN: A, B, C, D; COMPND 5 FRAGMENT: APSK2 HOMODIMER DOMAIN; COMPND 6 SYNONYM: PAPS SYNTHASE 2,PAPSS 2,SULFURYLASE KINASE 2,SK 2,SK2; COMPND 7 EC: 2.7.7.4,2.7.1.25; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PAPSS2, ATPSK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ADENOSINE 5'-PHOSPHOSULFATE KINASE DOMAIN 2, APSK2, HUMAN PAPSS2, KEYWDS 2 BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.ZHANG,W.Y.SONG,L.ZHANG REVDAT 2 19-JUL-23 8I1N 1 JRNL REVDAT 1 28-JUN-23 8I1N 0 JRNL AUTH L.ZHANG,W.SONG,T.LI,Y.MU,P.ZHANG,J.HU,H.LIN,J.ZHANG,H.GAO, JRNL AUTH 2 L.ZHANG JRNL TITL REDOX SWITCHING MECHANISM OF THE ADENOSINE 5'-PHOSPHOSULFATE JRNL TITL 2 KINASE DOMAIN (APSK2) OF HUMAN PAPS SYNTHASE 2. JRNL REF STRUCTURE V. 31 826 2023 JRNL REFN ISSN 0969-2126 JRNL PMID 37207644 JRNL DOI 10.1016/J.STR.2023.04.012 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.19 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 20342 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1003 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.1900 - 5.3600 0.99 3017 147 0.1890 0.2501 REMARK 3 2 5.3600 - 4.2500 1.00 2925 127 0.1816 0.2363 REMARK 3 3 4.2500 - 3.7200 0.99 2900 167 0.1939 0.2736 REMARK 3 4 3.7100 - 3.3800 0.99 2863 156 0.2274 0.3396 REMARK 3 5 3.3800 - 3.1300 0.98 2887 158 0.2457 0.3562 REMARK 3 6 3.1300 - 2.9500 0.95 2739 149 0.2563 0.3094 REMARK 3 7 2.9500 - 2.8000 0.70 2008 99 0.2450 0.2803 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 6393 REMARK 3 ANGLE : 1.400 8671 REMARK 3 CHIRALITY : 0.084 951 REMARK 3 PLANARITY : 0.008 1117 REMARK 3 DIHEDRAL : 28.811 967 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8I1N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1300034775. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JAN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9875 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21315 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.97400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.85400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2OFX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM CITRATE DIHYDRATE, REMARK 280 PH7.0 AND 20% W/V PEG3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.66450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 22 REMARK 465 HIS A 23 REMARK 465 ALA C 22 REMARK 465 HIS C 23 REMARK 465 ALA D 22 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO A 151 N PRO A 151 CA 0.201 REMARK 500 GLU B 156 CD GLU B 156 OE1 -0.110 REMARK 500 GLU B 156 CD GLU B 156 OE2 -0.097 REMARK 500 GLY C 90 C GLY C 90 O -0.118 REMARK 500 GLU C 171 CD GLU C 171 OE2 0.084 REMARK 500 GLU D 145 CD GLU D 145 OE2 0.097 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 151 C - N - CA ANGL. DEV. = 18.7 DEGREES REMARK 500 PHE B 60 CB - CG - CD2 ANGL. DEV. = -4.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 81 -50.19 -120.31 REMARK 500 ASP A 159 60.68 28.85 REMARK 500 ILE A 178 -65.69 -121.09 REMARK 500 ASN B 86 41.47 -106.54 REMARK 500 SER B 123 75.35 40.61 REMARK 500 THR B 187 56.17 -140.55 REMARK 500 ASP C 159 66.22 25.30 REMARK 500 ASP C 179 26.22 -140.82 REMARK 500 HIS D 24 149.55 85.01 REMARK 500 VAL D 81 -53.84 -123.91 REMARK 500 SER D 120 56.30 -140.73 REMARK 500 SER D 123 79.79 36.99 REMARK 500 ASP D 159 72.79 43.12 REMARK 500 ILE D 178 -78.73 -109.92 REMARK 500 GLU D 186 -31.71 -132.32 REMARK 500 PRO D 188 168.51 -49.64 REMARK 500 ILE D 215 -65.48 -100.26 REMARK 500 REMARK 500 REMARK: NULL DBREF 8I1N A 22 218 UNP O95340 PAPS2_HUMAN 22 218 DBREF 8I1N B 22 218 UNP O95340 PAPS2_HUMAN 22 218 DBREF 8I1N C 22 218 UNP O95340 PAPS2_HUMAN 22 218 DBREF 8I1N D 22 218 UNP O95340 PAPS2_HUMAN 22 218 SEQRES 1 A 197 ALA HIS HIS VAL SER ARG ASN LYS ARG GLY GLN VAL VAL SEQRES 2 A 197 GLY THR ARG GLY GLY PHE ARG GLY CYS THR VAL TRP LEU SEQRES 3 A 197 THR GLY LEU SER GLY ALA GLY LYS THR THR ILE SER PHE SEQRES 4 A 197 ALA LEU GLU GLU TYR LEU VAL SER HIS ALA ILE PRO CYS SEQRES 5 A 197 TYR SER LEU ASP GLY ASP ASN VAL ARG HIS GLY LEU ASN SEQRES 6 A 197 ARG ASN LEU GLY PHE SER PRO GLY ASP ARG GLU GLU ASN SEQRES 7 A 197 ILE ARG ARG ILE ALA GLU VAL ALA LYS LEU PHE ALA ASP SEQRES 8 A 197 ALA GLY LEU VAL CYS ILE THR SER PHE ILE SER PRO PHE SEQRES 9 A 197 ALA LYS ASP ARG GLU ASN ALA ARG LYS ILE HIS GLU SER SEQRES 10 A 197 ALA GLY LEU PRO PHE PHE GLU ILE PHE VAL ASP ALA PRO SEQRES 11 A 197 LEU ASN ILE CYS GLU SER ARG ASP VAL LYS GLY LEU TYR SEQRES 12 A 197 LYS ARG ALA ARG ALA GLY GLU ILE LYS GLY PHE THR GLY SEQRES 13 A 197 ILE ASP SER ASP TYR GLU LYS PRO GLU THR PRO GLU ARG SEQRES 14 A 197 VAL LEU LYS THR ASN LEU SER THR VAL SER ASP CYS VAL SEQRES 15 A 197 HIS GLN VAL VAL GLU LEU LEU GLN GLU GLN ASN ILE VAL SEQRES 16 A 197 PRO TYR SEQRES 1 B 197 ALA HIS HIS VAL SER ARG ASN LYS ARG GLY GLN VAL VAL SEQRES 2 B 197 GLY THR ARG GLY GLY PHE ARG GLY CYS THR VAL TRP LEU SEQRES 3 B 197 THR GLY LEU SER GLY ALA GLY LYS THR THR ILE SER PHE SEQRES 4 B 197 ALA LEU GLU GLU TYR LEU VAL SER HIS ALA ILE PRO CYS SEQRES 5 B 197 TYR SER LEU ASP GLY ASP ASN VAL ARG HIS GLY LEU ASN SEQRES 6 B 197 ARG ASN LEU GLY PHE SER PRO GLY ASP ARG GLU GLU ASN SEQRES 7 B 197 ILE ARG ARG ILE ALA GLU VAL ALA LYS LEU PHE ALA ASP SEQRES 8 B 197 ALA GLY LEU VAL CYS ILE THR SER PHE ILE SER PRO PHE SEQRES 9 B 197 ALA LYS ASP ARG GLU ASN ALA ARG LYS ILE HIS GLU SER SEQRES 10 B 197 ALA GLY LEU PRO PHE PHE GLU ILE PHE VAL ASP ALA PRO SEQRES 11 B 197 LEU ASN ILE CYS GLU SER ARG ASP VAL LYS GLY LEU TYR SEQRES 12 B 197 LYS ARG ALA ARG ALA GLY GLU ILE LYS GLY PHE THR GLY SEQRES 13 B 197 ILE ASP SER ASP TYR GLU LYS PRO GLU THR PRO GLU ARG SEQRES 14 B 197 VAL LEU LYS THR ASN LEU SER THR VAL SER ASP CYS VAL SEQRES 15 B 197 HIS GLN VAL VAL GLU LEU LEU GLN GLU GLN ASN ILE VAL SEQRES 16 B 197 PRO TYR SEQRES 1 C 197 ALA HIS HIS VAL SER ARG ASN LYS ARG GLY GLN VAL VAL SEQRES 2 C 197 GLY THR ARG GLY GLY PHE ARG GLY CYS THR VAL TRP LEU SEQRES 3 C 197 THR GLY LEU SER GLY ALA GLY LYS THR THR ILE SER PHE SEQRES 4 C 197 ALA LEU GLU GLU TYR LEU VAL SER HIS ALA ILE PRO CYS SEQRES 5 C 197 TYR SER LEU ASP GLY ASP ASN VAL ARG HIS GLY LEU ASN SEQRES 6 C 197 ARG ASN LEU GLY PHE SER PRO GLY ASP ARG GLU GLU ASN SEQRES 7 C 197 ILE ARG ARG ILE ALA GLU VAL ALA LYS LEU PHE ALA ASP SEQRES 8 C 197 ALA GLY LEU VAL CYS ILE THR SER PHE ILE SER PRO PHE SEQRES 9 C 197 ALA LYS ASP ARG GLU ASN ALA ARG LYS ILE HIS GLU SER SEQRES 10 C 197 ALA GLY LEU PRO PHE PHE GLU ILE PHE VAL ASP ALA PRO SEQRES 11 C 197 LEU ASN ILE CYS GLU SER ARG ASP VAL LYS GLY LEU TYR SEQRES 12 C 197 LYS ARG ALA ARG ALA GLY GLU ILE LYS GLY PHE THR GLY SEQRES 13 C 197 ILE ASP SER ASP TYR GLU LYS PRO GLU THR PRO GLU ARG SEQRES 14 C 197 VAL LEU LYS THR ASN LEU SER THR VAL SER ASP CYS VAL SEQRES 15 C 197 HIS GLN VAL VAL GLU LEU LEU GLN GLU GLN ASN ILE VAL SEQRES 16 C 197 PRO TYR SEQRES 1 D 197 ALA HIS HIS VAL SER ARG ASN LYS ARG GLY GLN VAL VAL SEQRES 2 D 197 GLY THR ARG GLY GLY PHE ARG GLY CYS THR VAL TRP LEU SEQRES 3 D 197 THR GLY LEU SER GLY ALA GLY LYS THR THR ILE SER PHE SEQRES 4 D 197 ALA LEU GLU GLU TYR LEU VAL SER HIS ALA ILE PRO CYS SEQRES 5 D 197 TYR SER LEU ASP GLY ASP ASN VAL ARG HIS GLY LEU ASN SEQRES 6 D 197 ARG ASN LEU GLY PHE SER PRO GLY ASP ARG GLU GLU ASN SEQRES 7 D 197 ILE ARG ARG ILE ALA GLU VAL ALA LYS LEU PHE ALA ASP SEQRES 8 D 197 ALA GLY LEU VAL CYS ILE THR SER PHE ILE SER PRO PHE SEQRES 9 D 197 ALA LYS ASP ARG GLU ASN ALA ARG LYS ILE HIS GLU SER SEQRES 10 D 197 ALA GLY LEU PRO PHE PHE GLU ILE PHE VAL ASP ALA PRO SEQRES 11 D 197 LEU ASN ILE CYS GLU SER ARG ASP VAL LYS GLY LEU TYR SEQRES 12 D 197 LYS ARG ALA ARG ALA GLY GLU ILE LYS GLY PHE THR GLY SEQRES 13 D 197 ILE ASP SER ASP TYR GLU LYS PRO GLU THR PRO GLU ARG SEQRES 14 D 197 VAL LEU LYS THR ASN LEU SER THR VAL SER ASP CYS VAL SEQRES 15 D 197 HIS GLN VAL VAL GLU LEU LEU GLN GLU GLN ASN ILE VAL SEQRES 16 D 197 PRO TYR HET ADP A 301 27 HET ADP B 301 27 HET ADX B 302 27 HET ADP C 301 27 HET ADX C 302 27 HET ADP D 301 27 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM ADX ADENOSINE-5'-PHOSPHOSULFATE FORMUL 5 ADP 4(C10 H15 N5 O10 P2) FORMUL 7 ADX 2(C10 H14 N5 O10 P S) HELIX 1 AA1 SER A 26 VAL A 34 1 9 HELIX 2 AA2 GLY A 54 HIS A 69 1 16 HELIX 3 AA3 ASP A 77 HIS A 83 1 7 HELIX 4 AA4 SER A 92 ALA A 113 1 22 HELIX 5 AA5 PHE A 125 ALA A 139 1 15 HELIX 6 AA6 PRO A 151 ASP A 159 1 9 HELIX 7 AA7 GLY A 162 GLY A 170 1 9 HELIX 8 AA8 THR A 198 GLN A 213 1 16 HELIX 9 AA9 SER B 26 VAL B 34 1 9 HELIX 10 AB1 GLY B 54 HIS B 69 1 16 HELIX 11 AB2 ASP B 77 ARG B 82 1 6 HELIX 12 AB3 SER B 92 ALA B 113 1 22 HELIX 13 AB4 PHE B 125 SER B 138 1 14 HELIX 14 AB5 PRO B 151 ASP B 159 1 9 HELIX 15 AB6 GLY B 162 ALA B 169 1 8 HELIX 16 AB7 THR B 198 GLN B 213 1 16 HELIX 17 AB8 SER C 26 GLN C 32 1 7 HELIX 18 AB9 GLY C 54 HIS C 69 1 16 HELIX 19 AC1 ASP C 77 HIS C 83 1 7 HELIX 20 AC2 SER C 92 ALA C 113 1 22 HELIX 21 AC3 PHE C 125 SER C 138 1 14 HELIX 22 AC4 PRO C 151 ASP C 159 1 9 HELIX 23 AC5 GLY C 162 ALA C 169 1 8 HELIX 24 AC6 THR C 198 GLN C 213 1 16 HELIX 25 AC7 SER D 26 GLY D 35 1 10 HELIX 26 AC8 GLY D 54 HIS D 69 1 16 HELIX 27 AC9 ASP D 77 ARG D 82 1 6 HELIX 28 AD1 SER D 92 ALA D 113 1 22 HELIX 29 AD2 PHE D 125 SER D 138 1 14 HELIX 30 AD3 PRO D 151 ASP D 159 1 9 HELIX 31 AD4 GLY D 162 ALA D 169 1 8 HELIX 32 AD5 THR D 198 GLN D 213 1 16 SHEET 1 AA1 5 CYS A 73 LEU A 76 0 SHEET 2 AA1 5 VAL A 116 THR A 119 1 O ILE A 118 N LEU A 76 SHEET 3 AA1 5 CYS A 43 THR A 48 1 N LEU A 47 O THR A 119 SHEET 4 AA1 5 PHE A 143 VAL A 148 1 O PHE A 144 N THR A 44 SHEET 5 AA1 5 ARG A 190 LEU A 192 1 O LEU A 192 N PHE A 147 SHEET 1 AA2 5 CYS B 73 LEU B 76 0 SHEET 2 AA2 5 VAL B 116 SER B 120 1 O ILE B 118 N LEU B 76 SHEET 3 AA2 5 CYS B 43 THR B 48 1 N VAL B 45 O THR B 119 SHEET 4 AA2 5 PHE B 143 ASP B 149 1 O ILE B 146 N TRP B 46 SHEET 5 AA2 5 ARG B 190 LYS B 193 1 O LEU B 192 N PHE B 147 SHEET 1 AA3 5 CYS C 73 LEU C 76 0 SHEET 2 AA3 5 VAL C 116 THR C 119 1 O ILE C 118 N TYR C 74 SHEET 3 AA3 5 CYS C 43 THR C 48 1 N LEU C 47 O THR C 119 SHEET 4 AA3 5 PHE C 143 ASP C 149 1 O PHE C 144 N TRP C 46 SHEET 5 AA3 5 ARG C 190 LYS C 193 1 O LEU C 192 N PHE C 147 SHEET 1 AA4 5 CYS D 73 LEU D 76 0 SHEET 2 AA4 5 VAL D 116 SER D 120 1 O ILE D 118 N LEU D 76 SHEET 3 AA4 5 CYS D 43 THR D 48 1 N VAL D 45 O CYS D 117 SHEET 4 AA4 5 PHE D 143 ASP D 149 1 O PHE D 144 N TRP D 46 SHEET 5 AA4 5 ARG D 190 LYS D 193 1 O LEU D 192 N PHE D 147 LINK N LYS B 55 O2B ADP B 301 1555 1555 1.32 CRYST1 75.594 71.329 89.986 90.00 114.82 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013229 0.000000 0.006117 0.00000 SCALE2 0.000000 0.014020 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012243 0.00000